DR CLARE WEEDEN
Success: Awarded with a Marie Sklodowska-Curie/European Respiratory Society
Cancer Type: Lung Cancer
Funded by The Peter Charody Grant, 2019
Based at the Walter and Eliza Hall Institute of Medical Research, Dr Clare Weeden’s latest breakthrough could see improved results for lung cancer patients.
“I’ve created a bank of patient tumour tissue that will allow further research into targeted therapies and enable more treatment options for lung cancer patients,” explains Clare. “I am excited to share soon our recent results regarding lung cancer in never-smokers, and how we might think about new treatments for these patients, as well further work into new cooperative immunotherapies for lung cancer.”
“My greatest achievements will always be our discoveries. If we aim to one day view cancer as a treatable disease, then research must be creative, collaborative, open, diverse, evidence-based, wide-ranging and challenging.
While currently preparing her manuscript for peer review, Clare will also soon undertake an exciting international opportunity. “I am delighted to share the news that I have been awarded a Marie Sklodowska-Curie/European Respiratory Society “RESPIRE4” fellowship to study lung cancer in non-smokers at Professor Charles Swanton’s laboratory in the Francis Crick Institute, London. I will begin my role within this prestigious group in 2021, where I will work with a team of bioinformaticians, clinicians and biologists dedicated to the study of lung cancer evolution and therapy.”
“We have seen what can happen when the world bands together to fund and conduct research with the advent of vaccines against COVID-19. Now imagine if this level of funding and synergy was applied to cancer…”
YOU CAN MAKE A DIFFERENCE TODAY
Donate to fund future researchers like Clare. Together, let’s make this the last generation to die from cancer.
We take on every cancer
Cure Cancer funds ground breaking research across every cancer, no matter the size or rarity.
We aim to maximise our impact, save millions of lives, and leaves no one behind.
Stay in touch with us
To receive updates on our work, campaigns and our impact in cancer research, subscribe to our newsletter here.